ASINEX

ASINEX Profile As a solution provider ASINEX offers unrivalled chemistry resources, many years of experience in providing discovery chemistry services and an ever expanding range of ADMET screening options. ASINEX's strength lies in the chemistry of small molecules, strongly supported by biology. Compound Libraries ASINEX’s skill in library design derives from its experience as a service provider principally of hit to lead and lead optimization chemistry. In the last few years we have been creating libraries designed to tackle notorious HTS bottlenecks such as novelty, diversity, solubility, lead-likeness and chemical flexibility. 1.Historical - 400,000 compounds 2.Synergy, LeadGen - 35,000 compounds (10,000+ pharmacophores) 3.High Value - 50,000 compounds (850 in-house templates) 4.Targeted Libraries – Kinase, GPCR, Protease, Ion Channel Chemistry Services To date ASINEX has completed more than 400 chemistry projects for 50 customers worldwide. Lead Optimization Custom Synthesis Exclusive Library Synthesis High Throughput Chemistry and Purification Biological Services: ADMET and DMPK Studies ASINEX Ltd 5 Gabrichevskogo St. Bldg 8 Moscow 123367 Russia Tel: +7 495 780 3417 amelvin@asinex.com www.asinex.com

Contact Details: 5 Gabrichevskogo St. Bldg 8 Moscow 123367 Russia Tel: +7 495 780 3417 Fax: Email: amelvin@asinex.com WWW: www.asinex.com

Recent Publications by ASINEX :
BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery. The analysis of known drugs (Comprehensive Medicinal Chemistry database...	27th May, 2009	ASINEX Ltd, 20 Geroev Panfilovtzev Str. Bldg 1, Moscow, 125480, Russia,	Mol Divers. 2009 May 26. DOI Direct Link

Press Releases on ASINEX :
Collaborative Drug Discovery 2nd Annual Community Meeting - Oct. 7, 2008, Speakers Confirmed & Call for Posters	31st July, 2008	Collaborative Drug Discovery, Inc.	BURLINGAME, Calif., July 31 /PRNewswire/ -- Collaborative Drug Discovery invites you to submit your poster presentation and register at http://www.acteva.com/go/cdd to attend the 2nd Annual CDD
ATUGEN AND ASINEX ANNOUNCE DISCOVERY PROGRAM FOR NOVEL PROTEIN KINASE	1st February, 2005	Atugen	ATUGEN AND ASINEX ANNOUNCE DISCOVERY PROGRAM FOR NOVEL PROTEIN KINASE
ASINEX LTD. AND RECORDATI S.P.A. ANNOUNCE AN INTEGRATED DRUG DISCOVERY	1st October, 2004	Asinex	ASINEX LTD. AND RECORDATI S.P.A. ANNOUNCE AN INTEGRATED DRUG DISCOVERY PROJECT Milan, 19 October 2004 – ASINEX Ltd, a worldwide leader in lead generation and lead
ASINEX Announces One Year Extension to Collaboration with Johnson and	1st June, 2002	Asinex	ASINEX Announces One Year Extension to Collaboration with Johnson and Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V (J&
ASINEX announces successful Lead Optimization project with Asahi Kasei	1st January, 1970	Asinex	ASINEX announces successful Lead Optimization project with Asahi Kasei Moscow, October 2003 — ASINEX, a leading European provider of Lead Generation and Optimization

BioNews Results for ASINEX :
3rd Annual Collaborative Drug Discovery - UCSF Community Meeting for Catalyzing Humanitarian and Commercial Re	PR Newswire:  Sep 15 2009 6:28PM Matching: asinex

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 748 times since April 2007, the link to the organisation's website has been followed 102 times

Recent Search Terms used to find this page: asinex | asinex | asinsex and the city quotes | asinex | asinex | asinsex | asinsex | Asinex lead-likeness library | asinex | asine | .

Search for more companies in Moscow

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for ASINEX